U.S. FDA advisers back Pfizer arthritis drug
WASHINGTON (Reuters) – Pfizer Inc won a U.S. advisory panel’s support on Wednesday for its arthritis drug
WASHINGTON (Reuters) – Pfizer Inc won a U.S. advisory panel’s support on Wednesday for its arthritis drug
WASHINGTON (Reuters) – U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc’s experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections
Dr. Sanjay Gupta reports on Cellulaze, a new FDA-approved procedure some say may be a long-term solution to cellulite
WASHINGTON (Reuters) – HeartWare International Inc won a U.S. advisory panel’s support on Wednesday for its most important product — a blood pump that helps people with severe heart failure
Since 2009 the Food and Drug Administration (FDA) has mandated that Plan B and other emergency contraceptives be available without a prescription to women age 17 and up. In reality, a new study suggests, a 17-year-old’s access to these drugs can be uncertain
Recent Comments